Thrive Therapeutic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.80 Cr
- Revenue Growth 24.28%
- Profit Growth 17.41%
- Ebitda -26.72%
- Net Worth 18.62%
- Total Assets -51.11%
About Thrive Therapeutic
Thrive Therapeutic Private Limited (TTPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 April 2008 and has a history of 16 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.80 Cr.
Sudha Singh, Akansha Singh, Astha Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2008PTC180854
-
Company No.
180854
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Thrive Therapeutic?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akansha Singh
|
Director | 03-Mar-2022 | Current |
|
Sudha Singh
|
Director | 23-Dec-2020 | Current |
|
Astha Singh
|
Director | 03-Mar-2022 | Current |
|
Anand Kumar
|
Director | 04-Apr-2008 | Current |
Financial Performance of Thrive Therapeutic.
Thrive Therapeutic Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 24.28% increase. The company also saw a substantial improvement in profitability, with a 17.41% increase in profit. The company's net worth Soared by an impressive increase of 18.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thrive Therapeutic?
In 2020, Thrive Therapeutic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shree Kisun Singh Laboratories Private LimitedSudha Singh and Anand Kumar are mutual person
-
Shreecure Pharmaceuticals Private Limited
Anand Kumar is a mutual person
Charges (Loans)
₹18.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2024 | Others | ₹1.80 Cr | Open |
How Many Employees Work at Thrive Therapeutic?
Unlock and access historical data on people associated with Thrive Therapeutic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thrive Therapeutic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thrive Therapeutic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
